Digital Health Startup Omada Snags Another $73 Million in Funding: Brainstorm HealthOmada Health raised $73 million at a reported $600 million valuation for its digital diabetes prevention platform.
What the $63 Billion AbbVie Allergan Deal Says About the Drug Industry: Brainstorm HealthAbbVie's acquisition of the Botox maker isn't a great reflection on the state of big pharma innovation.
San Francisco Is the First U.S. City to Ban E-Cigarette SalesYes, even San Francisco-based Juul's products.
Recreational Marijuana Is Now Legal in 11 StatesIllinois became the 11th state to legalize recreational marijuana on Monday, which could lead to expunging the records of nearly 800,000.
What AbbVie's $63 Billion Deal to Buy Allergan Says About the Drug IndustryAbbVie, maker of the world's best-selling drug, is buying Botox maker Allergan in a blockbuster deal. Here's what that says about the state of biopharma.
AbbVie Is Buying Botox Maker Allergan in Blockbuster $63 Billion DealIt's the latest mega-deal in the health space.
Bristol-Myers Squibb Loses $6 Billion in Value on Celgene Deal Setback: Brainstorm HealthBristol Myers surprised investors, announcing it would spin off Celgene's popular drug Otezla to address antitrust concerns.
Skip to Content
